Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Estriol tripropionate is a semisynthetic steroidal estrogen and an ester derivative of estriol. It is marketed under the brand name Estriel and used as an estrogen medication. As an estrogen ester, it acts primarily as a prodrug for estriol, which exerts its effects by agonizing the estrogen receptor (ER). Estriol itself is considered a weak estrogen compared to other endogenous estrogens like estradiol. The primary clinical use of estriol esters such as estriol tripropionate has been in menopausal hormone therapy to treat symptoms like hot flashes and vaginal dryness. The drug is administered via intramuscular injection[5][3]. Its mechanism involves binding to nuclear estrogen receptors to modulate gene transcription and mediate typical estrogenic effects in target tissues[2][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on estriol tripropionate.